Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Cellular Signalling|July 5, 2005
Protein kinase C zeta associates with death inducing signaling complex and regulates Fas ligand-induced apoptosisIngrid Leroy, Aurélie de Thonel, Guy Laurent, et al.Leukemia & Lymphoma|January 2, 2025
The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemiaLoic Ysebaert, Pierre-Luc Mouchel, Camille Laurent, et al.Cellular Signalling|January 30, 2007
Granzyme B induction signalling pathway in acute myeloid leukemia cell lines stimulated by tumor necrosis factor alpha and Fas ligandFabien Guilloton, Christine Jean, Aurélie de Thonel, et al.Cancers|November 12, 2013
Cancer stem cells of differentiated B-cell malignancies: models and consequencesEmilie Gross, Anne Quillet-Mary, Loic Ysebaert, et al.Leukemia & Lymphoma|October 26, 2011
Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cellsCecile Liffraud, Anne Quillet-Mary, Jean-Jacques Fournié, et al.Frontiers in Immunology|March 18, 2021
Lymphoma Heterogeneity Unraveled by Single-Cell TranscriptomicsLoic Ysebaert, Anne Quillet-Mary, Marie Tosolini, et al.The Biochemical Journal|March 10, 2007
PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide productionAlexandra Charruyer, Christine Jean, Audrey Colomba, et al.British Journal of Haematology|July 26, 2002
Protein kinase C-zeta overexpression induces erythroid phenotype in the monocytic leukaemia cell line U937Véronique Mansat-De Mas, Aurélie de Thonel, Vanessa Gaulin, et al.Molecular Pharmacology|November 19, 2002
Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activationChristine Bezombes, Aurélie de Thonel, Andriana Apostolou, et al.Oncotarget|September 9, 2017
Nurse-like cells promote CLL survival through LFA-3/CD2 interactionsFrédéric Boissard, Marie Tosolini, Laetitia Ligat, et al.Pageof 4